Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aditi Bagchi

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2025
Infant-Type Hemispheric Gliomas: A Review of Clinical, Radiologic, Histopathologic, and Molecular FeaturesAditi Bagchi, Jason Chiang, Soniya Pinto, et al.
Cancer Reports (Hoboken, N.J.)|August 5, 2021
Rare cases of medulloblastoma with hypermutationAditi Bagchi, Ian Beddows, Albert Cornelius, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 29, 2023
Molecular Classification Improves Therapeutic Options for Infants and Young Children With MedulloblastomaAditi Bagchi, Sandeep K Dhanda, Paige Dunphy, et al.
Nature Communications|February 9, 2016
KRAS insertion mutations are oncogenic and exhibit distinct functional propertiesYasmine White, Aditi Bagchi, Jessica Van Ziffle, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|March 1, 2021
Impact of Preanalytical Factors on the Measurement of Tumor Tissue Biomarkers Using ImmunohistochemistryAditi Bagchi, Zachary Madaj, Kelly B Engel, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2025
Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusionsAmi V Desai, Aditi Bagchi, Amy E Armstrong, et al.
Neuro-Oncology|July 28, 2023
High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experienceJason Chiang, Aditi Bagchi, Xiaoyu Li, et al.
Molecular Cancer|June 7, 2024
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapyMarc Zuckermann, Chen He, Jared Andrews, et al.
Neuro-Oncology|November 9, 2025
A Systematic Study of Molecular Diagnosis, Treatment and Prognosis in Infant-Type Hemispheric Glioma): An Individual Patient Data Meta-analysis of 164 patientsLara Chavaz, Aditi Bagchi, Sandeep K Dhanda, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2025
Infant-Type Hemispheric Gliomas: A Review of Clinical, Radiologic, Histopathologic, and Molecular FeaturesAditi Bagchi, Jason Chiang, Soniya Pinto, et al.
Cancer Reports (Hoboken, N.J.)|August 5, 2021
Rare cases of medulloblastoma with hypermutationAditi Bagchi, Ian Beddows, Albert Cornelius, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 29, 2023
Molecular Classification Improves Therapeutic Options for Infants and Young Children With MedulloblastomaAditi Bagchi, Sandeep K Dhanda, Paige Dunphy, et al.
Nature Communications|February 9, 2016
KRAS insertion mutations are oncogenic and exhibit distinct functional propertiesYasmine White, Aditi Bagchi, Jessica Van Ziffle, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|March 1, 2021
Impact of Preanalytical Factors on the Measurement of Tumor Tissue Biomarkers Using ImmunohistochemistryAditi Bagchi, Zachary Madaj, Kelly B Engel, et al.
European Journal of Cancer (Oxford, England : 1990)|March 14, 2025
Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusionsAmi V Desai, Aditi Bagchi, Amy E Armstrong, et al.
Neuro-Oncology|July 28, 2023
High-grade glioma in infants and young children is histologically, molecularly, and clinically diverse: Results from the SJYC07 trial and institutional experienceJason Chiang, Aditi Bagchi, Xiaoyu Li, et al.
Molecular Cancer|June 7, 2024
Capmatinib is an effective treatment for MET-fusion driven pediatric high-grade glioma and synergizes with radiotherapyMarc Zuckermann, Chen He, Jared Andrews, et al.
Neuro-Oncology|November 9, 2025
A Systematic Study of Molecular Diagnosis, Treatment and Prognosis in Infant-Type Hemispheric Glioma): An Individual Patient Data Meta-analysis of 164 patientsLara Chavaz, Aditi Bagchi, Sandeep K Dhanda, et al.
Pageof 1